Literature DB >> 7569349

Phakic retinal detachments in the elderly.

C P Wilkinson1.   

Abstract

PURPOSE: To discover if clinical nontraumatic phakic retinal detachments in the elderly possess characteristics that distinguish them from similar cases in younger persons.
METHODS: A retrospective study of 100 consecutive cases in patients aged 70 years and older was performed. Recorded data included patient age and sex, type and location of retinal break, extent of detachment, and associated vitreoretinal pathology.
RESULTS: Approximately 90% of retinal breaks were horseshoe tears, and the majority were located in the superior temporal quadrant. Horseshoe tears confined to the posterior margin of the vitreous base were responsible for retinal detachments in 30% of cases, and an additional 36% of breaks were located anterior to the equator.
CONCLUSION: The incidence of this type of anterior break is higher than that previously described for phakic retinal detachments, although previous studies have not discussed break types as a function of old age. Anterior horseshoe tears, which cause many phakic retinal detachments in the elderly, may not be caused by acute posterior vitreous detachment, but rather to persistent chronic traction on the vitreous base after posterior vitreous detachment.

Entities:  

Mesh:

Year:  1995        PMID: 7569349     DOI: 10.1097/00006982-199515030-00006

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Characteristics of rhegmatogenous retinal detachment in pseudophakic and phakic eyes.

Authors:  O A R Mahroo; R Dybowski; R Wong; T H Williamson
Journal:  Eye (Lond)       Date:  2012-06-08       Impact factor: 3.775

2.  Preoperative B-scan ultrasonography of the vitreoretinal interface in phakic patients undergoing rhegmatogenous retinal detachment repair and its prognostic significance.

Authors:  Flávio A Rezende; Michael A Kapusta; Miguel N Burnier; Rogério A Costa; Ingrid U Scott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.